Shang-Yin Wu

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

Kwang‐Yu Chang, Nai‐Jung Chiang, Shang-Yin Wu et al. · OncoImmunology · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

Yuh-Min Chen, James Chih‐Hsin Yang, Wu‐Chou Su et al. · Journal of the Formosan Medical Association · 2020 · 12 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16